As a comparison, here are the findings from trials of other weight loss drugs: Semaglutide : Participants taking weekly 2.4 mg doses of semaglutide (Wegovys active ingredient) lost an estimated average of 14.9% of their body weight by the end of a 68-week trial
10.1016/j.addr.2023.115109 16 ChenM
Sa ong cha ti (60mg) : gip tng cng sc khe ton din, lm chm qu trnh lo ha, ng thi dng m cho da, mang li ln da mm mi v mn mng
Subcutaneous administration allows for gradual, controlled absorption of the medication into the bloodstream, which helps maintain stable drug levels and minimize adverse effects
It enhances intracellular GSH synthesis and acts as both a direct and indirect antioxidant, scavenging major oxidants such as OH, NO 2 , and thiyl radicals, though less effectively against superoxide and hydrogen peroxide (3)
Later, Viswanathan et al